The North American microbiology market is growing due to the increase in the prevalence of pathogenic diseases, growth in discovery of mutating and adapting bacterium, and the growing need for speedy microbiological testing methods.
The clinical microbiology laboratory has a whole array of diagnostics instruments used for serology, virus culture, and blood culture. This method is used for the detection of influenza viruses as well as a number of other diseases. Clinical microbiology testing is indispensable for identifying bacterial, fungal, and parasitic infections as well as for preventing epidemics. It also helps in the clinical management of patients. The rapid diagnostic testing market is the most sought after in the microbiology industry as it provides results in less than 30 minutes. Thus, a faster turnaround time (TAT) and immediate results are the major factors that will drive the microbiology market.
There has been an increase in the number of infectious diseases across the globe. The factors driving the microbiology market are the rise in incidence of HIV and tuberculosis, as well as sexually transmitted diseases in developing countries along with the rise in respiratory diseases like influenza in developed countries like Europe and America.
Technological advances, like automated instruments for identification of pathogens in laboratories have been of immense help to microbiologists. Automation has helped to enhance key laboratory performance attributes like consistency, quality, and a slower total turnaround time. Thus, automation is the new trend in the microbiology field. However, this trend will take time to develop, as it requires extensive training of laboratory personnel. These machines are helping medical practitioners receive accurate data and determine the precise course of treatment without spending too much time.
Similarly, factors like the consolidation of diagnostic laboratory chains and the increase in public awareness are driving the growth of the market. The emerging countries are expected to outperform the U.S. and European countries. This is mainly due to the increase in major hospital chains opening new centers in major cities in these regions and an increase in government expenditure.
The Centers for Medicare & Medicaid Services (CMS) has estimated that healthcare spending in the U.S. is expected to grow from $2.7 trillion in 2011 to $4.6 trillion in 2018, at a CAGR of 6.8%, for the given period. Similarly, in emerging countries, awareness and an increasing middle-class population, with a more disposable income to spend on healthcare, will be a driving force for the growth of this market.
The report ‘North American Microbiology Market forecast for 2018’ analyzes the market by segments such as microbiology instruments and microbiology reagents.
The Americas commanded the largest share 42% in the global microbiology market with $1485.02 million in 2013, and is expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.
The U.S. commanded the largest share of 89% in the North American microbiology IVD market with $1320.4 million in 2012, and is expected to reach $1715.6 million by 2017, at a CAGR of 5.6% from 2013 to 2018.
The report also provides an extensive competitive landscaping of companies operating in this market. The leading players in the microbiology market are bioMerieux SA (France), Becton Dickinson and company (U.S.), and Siemens (Germany). Segment and country-specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
- Unmet needs, revenue pockets, and potential areas for expansion in microbiology market
- Comprehensive review of key suppliers of analyzers, POC, and slide and imaging manufacturers
Extensive Market Data
- Number of hospitals, public health laboratories, private laboratories, and blood banks for microbiology market
Current and Emerging Products
- Analysis of the current and emerging microbiology and immunodiagnostic tests
- Review of the current instrumentation technologies in microbiology market
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact analysis
MMM’s healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure).
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
North America In Vitro Diagnostics
In 2013, the Americas had the largest market, a 42% share of the Global IVD market, followed by Europe with a 31% share. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. The report “North American In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users.
Europe In Vitro Diagnostics
In 2013, the Americas had the largest market, a 42% share of the European IVD market, followed by Europe with a 31% share. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. The report “European In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users. Germany commanded the largest share in European IVD market.
Asia In Vitro Diagnostics
Asian IVD market is growing in double digit and will continue to grow in future. China commanded the largest share in Asian IVD market. The report “Asian In Vitro Diagnostics Market forecast for 2018 “analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users.